Molecular and Cellular Biochemistry

, Volume 189, Issue 1–2, pp 41–46 | Cite as

Immuno-detection of aluminium and aluminium induced conformational changes in calmodulin - implications in Alzheimer's disease

  • Raphael Levi
  • Tamar Wolf
  • Gideon Fleminger
  • Beka Solomon


Binding of calcium to calmodulin (CAM) induces specific structural rearrangements in the whole protein molecule. Ca2+ organizes and stabilizes the four-domains structure of calmodulin in a helical, active conformation that can bind to its target proteins; the central helix remaining flexible is an essential condition for their bio-recognition. The conformation of calmodulin, and its efficacy to interact with target proteins, is profoundly altered when bound to metal ions other than calcium. As recently reported, the local structural changes of CaM, which occur upon aluminium binding, lead to the impairment of protein flexibility and to the loss of its ability to interact with several other proteins, which may decrease or inhibit the regulatory character of calmodulin. In this study we followed conformational changes occurring in the calmodulin molecule after aluminium binding using highly specific monoclonal antibodies (mAbs) able to differentiate between the conformational states of calmodulin, as well as mAbs which recognize aluminium free or bound to proteins. Under the same experimental conditions, mAb CAM-1, a Ca2+ conformation sensitive antibody raised against calmodulin, fails to recognize the calmodulin-aluminium complex, despite the presence of Ca2+, while the anti-Al antibodies show a maximal binding pattern towards their antigen. These data suggest that Al3+ ions bind to calmodulin in the presence of Ca2+ ions, leading to an inactive, reversible conformation, instead of its physiological active form. Alteration of the conformation of calmodulin imposed by Al binding may have possible implications in the neurotoxicity mechanism related to Alzheimer's disease.

calmodulin aluminium monoclonal antibodies confirmation Alzheimer's disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cheung WY: Calmodulin: An overview. FASEB (Federation Proceedings) 41(7): 2253–2256, 1982Google Scholar
  2. 2.
    Crivici A, Ikuta M: Molecular and structural basis of target recognition by calmodulin. Ann Rev Biophys Biomol Struct 24: 85–116, 1995Google Scholar
  3. 3.
    Martin RB: Chemistry of aluminum in the central nervous system. In: M. Yasui, M.J. Strong, K. Ota, M.A. Verity (eds). Min. Metal Neurotoxicol CRC, Boca Raton, 1997, pp 75–80Google Scholar
  4. 4.
    Siegel H, Haug A: Aluminium interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim Biophys Acta 744: 36–45, 1982Google Scholar
  5. 5.
    Weis C, Haug A: Aluminium‐induced conformational changes in calmodulin alter the dynamics of interaction with melittin. Arch Biochem Biophys 254(l): 304–312, 1987Google Scholar
  6. 6.
    LaPorte DC, Wierman BM, Storm DR: Calcium‐induced exposure of a hydrophobic surface on calmodulin. Biochemistry 19: 3814–3819, 1980Google Scholar
  7. 7.
    Haug A, Vitorello V: Aluminium coordination to calmodulin: thermodynamic and kinetic aspects. Coord Chem Rev 149: 113–124, 1996Google Scholar
  8. 8.
    Nicolini M, Zatta PF, Corain B (eds.) Aluminum in Chemistry Biology and Medicine. A Series of Advances. Vol. 1. Raven Press/New York, 1991Google Scholar
  9. 9.
    Birchall JD, Chappell JS: Aluminium chemical physiology and Alzheimer’s disease. The Lancet Oct 29: 1008–1010, 1988Google Scholar
  10. 10.
    Birchall JD, Chappell JS: The chemistry of aluminium and silicon in relation to Alzheimer’s disease. Clin Chem 34: 265–267, 1988Google Scholar
  11. 11.
    Eichhorn GL: Is there any relationship between aluminium and Alzheimer’s disease? Exp Gerontol 28: 493–498, 1993Google Scholar
  12. 12.
    Corrigan FM, Reynolds GV, Ward NI: Hippocampal tin, aluminium and zinc in Alzheimer’s disease. BioMetals 6: 149–152, 1993Google Scholar
  13. 13.
    Pearl DP, Brody RD: Alzheimer’s disease: X‐ray spectrometric evidence of aluminium accumulation in neurofibrillary tangle‐bearing neurons. Science 208: 297–298, 1980Google Scholar
  14. 14.
    Shin RW, Lee VM, Trojanowski JQ: Aluminum modifies the properties of Alzheimer’s disease PHFτ Proteins in vivo and in vitro. J Neurosci 14(1l): 7221–7233, 1994Google Scholar
  15. 15.
    Abdel‐Ghany M, El‐Sebae AK, Shalloway D: Aluminum‐induced nonenzymatic phospho‐incorporation into human tau and other proteins. J Biol Chem 268(16): 11976–11980, 1993Google Scholar
  16. 16.
    Scott CW, Fieles A, Sygowski LA, Caputo CB: Aggregation of tau protein by aluminum. Brain Res 628: 77–84, 1993Google Scholar
  17. 17.
    Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE: Aluminium, iron and zinc ions promote aggregation of physiological concentrations of amyloid peptide. J Neurochem 61(3): 1171–1173, 1993Google Scholar
  18. 18.
    Exley C, Price NC, Kelly SM, Birchall JD: An interaction of β‐amyloid with aluminium in vitro FEBS 324(3): 293–295, 1993Google Scholar
  19. 19.
    Kuroda Y, Kawahara M: Aggregation of amyloid β‐protein and its neurotoxicity: Enhancement by aluminum and other metals. J Exp Med 174: 263–268, 1994Google Scholar
  20. 20.
    Hollosi M, Shen ZM, Perczel A, Fasman GD: Stable interchain complexes of neurofilament peptides: A putative link between Al+3 and Alzheimer disease. Proc Natl Acad Sci USA 91: 4902–4906, 1994Google Scholar
  21. 21.
    Baudier J, Mochly‐Rosen D, Newton A, Lee SH, Koshland DE Jr., Cole RD: Comparison of S100b protein with calmodulin: interactions with melittin and microtubule‐associated τ ?proteins and inhibition of phosphorylation of τ? protein by protein kinase C. Biochemistry 26: 2886–2893, 1987Google Scholar
  22. 22.
    Marshak RD, Pesce SA, Stanley LC, Griffin WST: Increased S100b neurotrophic activity in Alzheimer’s disease temporal lobe. Neurobiol Aging 13(l): 1–7, 1992Google Scholar
  23. 23.
    Heizmann CW, Braun K: Changes in CA2+ binding proteins in human neurodegenerative disorders. TINS 15: 259–264, 1992Google Scholar
  24. 24.
    Gandhi CR, Keenan RW: The role of calmodulin in the regulation of dolichol kinase. J Biol Chem 258: 7639–7643, 1983Google Scholar
  25. 25.
    Cheung WY: Calmodulin plays a pivotal role in cellular regulation. Science 207: 19–27, 1980Google Scholar
  26. 26.
    Crapper McLachlan RD, Wong L, Bergeron C, Baimbridge KG: Calmodulin and Calbindin D28K in Alzheimer’s disease. Alzheimer Disease and Associated Disorders 1(3): 171–179, 1987Google Scholar
  27. 27.
    Wolf T, Fleminger G, Solomon B: Functional conformations of calmodulin: I. Preparation and characterization of a conformational specific anti‐bovine calmodulin monoclonal antibody. J Mol Recog 8: 67–71, 1995Google Scholar
  28. 28.
    Ivnitski D, Wolf T, Solomon B, Fleminger G, Rishpon J: An amperometric biosensor for real time analysis of molecular recognition. Bioelectrochem Bioen (In Press)Google Scholar
  29. 29.
    Wolf T, Solomon B, Ivnitski D, Rishpon J, Fleminger G: Interactions of calmodulin with metal ions with its target proteins revealed by conformation‐sensitive monoclonal antibodies. J Mol Recog (In Press)Google Scholar
  30. 30.
    Levi R, Shohat L, Solomon B: Specificity of an anti‐aluminium monoclonal antibody towards free and protein‐bound aluminium. J Inorg Biochem 69: 159–163, 1998Google Scholar
  31. 31.
    Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495–497, 1975Google Scholar
  32. 32.
    Solomon B, Koppel R, Kennet D, Fleminger G: Localization of a highly immunogenic region of carboxypeptidase A recognized by three different monoclonal antibodies and their use in the detection of subtle conformational alterations in this enzyme region. Biochem 28: 1235–1241, 1989Google Scholar
  33. 33.
    Richardt G, Federolf G, Hambermann E: The interaction of aluminium and other metal ions with calcium‐calmodulin‐dependent phosphodiesterase. Arch Toxicol 57: 257–259, 1985Google Scholar
  34. 34.
    Suhayda CG, Haug A: Citrate chelation as a potential mechanism against aluminium toxicity in cells: The role of calmodulin. Can J Biochem 63: 1167–1175, 1985Google Scholar
  35. 35.
    Suhayda CG, Haug A: Organic acids prevent aluminium‐induced conformational changes in calmodulin. Biochem Biophys Res Commun 119: 376–381, 1984Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Raphael Levi
    • 1
  • Tamar Wolf
    • 1
  • Gideon Fleminger
    • 1
  • Beka Solomon
    • 1
  1. 1.Department of Molecular Microbiology and Biotechnology, Faculty of Life SciencesTel-Aviv UniversityRamat AvivIsrael

Personalised recommendations